PlexusDx Oral Tirzepatide is $349/mo month-to-month (or $279/mo on the 6-month plan) flat across all commitment tiers, with HSA/FSA eligibility and no insurance required
Drugs that target the GLP-1 (glucagon-like peptide-1) receptor, sometimes referred to as GLP-1 receptor agonists, have long been authorized for the treatment of type 2 diabetes
Telehealth subscription models: Monthly medication + consultation: $200-$400 all-inclusive pricing
Lancet 400(10366):18691881 Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S et al (2023) Retatrutide phase 2 obesity trial investigators
Liraglutide is typically dosed accordingly for T2D: Initiated at a dosage of 0.6mg per day for one week, administered subcutaneously at any time of the day, regardless of meals